Biotechnology

Filter

Current filters:

None

Popular Filters

63 to 87 of 2557 results

CTI BioPharma and Baxter’s pacritinib meets primary endpoint in myelofibrosis trial

CTI BioPharma and Baxter’s pacritinib meets primary endpoint in myelofibrosis trial

10-03-2015

US biotech firm CTI BioPharma saw its shares rise 6.4% to $2.82 on Monday, after the company, along with…

Baxter InternationalBiotechnologyCTI BioPharmaOncologypacritinibResearch

Unanimous FDA advisory panel backing for KYTHERA’s ATX-101

Unanimous FDA advisory panel backing for KYTHERA’s ATX-101

10-03-2015

US biotech firm KYTHERA Biopharmaceuticals said yesterday that the US Food and Drug Administration's…

ATX-101BayerBiotechnologyDermatologicalsKYTHERA BiopharmaceuticalsRegulationUSA

EMD Serono and Opexa amend deal on MS drug candidate Tcelna

EMD Serono and Opexa amend deal on MS drug candidate Tcelna

09-03-2015

EMD Serono, the US biopharmaceutical division of Germany’s Merck KGaA has amended its agreement with…

BiotechnologyEMD SeronoFinancialLicensingMerck KGaANeurologicalOpexa TherapeuticsResearchTcelna

Arrowhead acquires Novartis' RNAi R&D portfolio

Arrowhead acquires Novartis' RNAi R&D portfolio

07-03-2015

USA-based nano-medicine developer Arrowhead Research Corp revealed on Thursday that it has acquired Swiss…

Arrowhead ResearchArrowhead Research CorpBiotechnologyLicensingNovartis

Targacept and Catalyst Biosciences agree to merge

Targacept and Catalyst Biosciences agree to merge

07-03-2015

Targacept and fellow USA-based Catalyst Biosciences, a privately held biopharmaceutical firm, have entered…

BiotechnologyCatalyst BiosciencesHematologyMergers & AcquisitionsTargacept

Adocia opens US subsidiary and appoints Simon Bruce and Stephen Daly

Adocia opens US subsidiary and appoints Simon Bruce and Stephen Daly

06-03-2015

French biotech company Adocia has created a US subsidiary, Adocia Incorporated, and appointed Simon Bruce…

AdociaAdocia IncorporatedBiotechnologyBoardroomUnited States

Sandoz’s Zarxio first biosimilar to be approved under new FDA pathway

Sandoz’s Zarxio first biosimilar to be approved under new FDA pathway

06-03-2015

Sandoz, the generics unit of Swiss pharma giant Novartis, today received approval from the US Food and…

AmgenBiosimilarsBiotechnologyNeupogenNovartisOncologyRegulationSandozUSAZarxioZarzio

Megafunds could solve biotech financing and unlock new orphan drug funding

Megafunds could solve biotech financing and unlock new orphan drug funding

06-03-2015

A new financing technique could reduce the risk associated with investing in the treatment of new diseases…

BiotechnologyFinancialHealthMedicineNational Center for Advancing Translational Studies

Gates Foundation makes $52 million investment in CureVac

Gates Foundation makes $52 million investment in CureVac

06-03-2015

The Bill & Melinda Gates Foundation has committed to invest $52 million in private biopharma company…

BiotechnologyBusiness FinanceCureVacHealth Medical PharmaUnited States

Spero Therapeutics gains rights to novel anti-infectives developed at HZI

Spero Therapeutics gains rights to novel anti-infectives developed at HZI

06-03-2015

Ascenion, the technology transfer partner of Germany’s Helmholtz Center for Infection Research (HZI),…

Antibiotics and Infectious diseasesBiotechnologyLicensingResearchSpero Therapeutics

AOP Orphan updates on Phase III trial PROUD-PV applying ropeginterferon

06-03-2015

Austria-based rare diseases specialist AOP Orphan Pharmaceuticals has completed recruitment for its Phase…

AOP Orphan PharmaceuticalsBiotechnologyPharmaEssentiaRare diseasesResearchropeginterferon alfa 2b

Norgine partners with Navidea for Lymphoseek marketing in Europe

05-03-2015

Netherlands-headquartered independent drugmaker Norgine says that its affiliate, SpePharm AG, has entered…

BiotechnologyEuropeLicensingLymphoseekNavidea BiopharmaceuticalsNorgineOncology

US biosimilar approvals poised to grow, but market uptake faces challenges, says Tufts CSDD

05-03-2015

Biosimilar approvals in the USA are expected to increase during the next five years, but safety concerns…

BiosimilarsBiotechnologyFinancialMarkets & MarketingRegulationUSA

US FDA expands use of Bristol-Myers’ Opdivo to NSCLC

US FDA expands use of Bristol-Myers’ Opdivo to NSCLC

05-03-2015

The US Food and Drug Administration late yesterday expanded the approved use of pharma major Bristol-Myers…

BiotechnologyBristol-Myers SquibbOncologyOpdivoRegulationUSA

Novogen’s TRXE-009 kills brain cancer stem cells

Novogen’s TRXE-009 kills brain cancer stem cells

05-03-2015

Shares of Australian biotech company Novogen rose dramatically as it announced that one of its lead candidate…

AustraliaBiotechnologyNovogenOncologyResearch

Baxter acquires biopharmaceutical firm SuppreMol

Baxter acquires biopharmaceutical firm SuppreMol

04-03-2015

US health care product company Baxter International has acquired SuppreMol GmbH for 200 million euros…

Baxter InternationalBiotechnologyImmunologicalsSuppreMol

FDA accepts Bayer's BLA for hemophilia A agent Kovaltry

FDA accepts Bayer's BLA for hemophilia A agent Kovaltry

04-03-2015

The US Food and Drug Administration has accepted German pharma major Bayer’s Biologics License Application…

BAY 81-8973BayerBiotechnologyHematologyKovaltryRegulationUSA

arGEN-X exercises option on ARGX-115 to target immune checkpoint in cancer

arGEN-X exercises option on ARGX-115 to target immune checkpoint in cancer

04-03-2015

Clinical-stage biopharma company arGEN-X has exercised its option to exclusively license preclinical…

arGEN-XBelgiumBiotechnologyLicensingOncology

Bristol-Myers will lead immuno-oncology market in 2022, say analysts

Bristol-Myers will lead immuno-oncology market in 2022, say analysts

04-03-2015

Analysts at Morningstar Equity Research see significantly more opportunity than the overall market for…

AstraZenecaBiotechnologyBristol-Myers SquibbMarkets & MarketingMerck & CoOncologyOpdivoResearchRoche

FDA formally accepts Actelion's NDA for Uptravi

FDA formally accepts Actelion's NDA for Uptravi

04-03-2015

Switzerland-based Actelion, Europe’s largest biotech company, says that the US Food and Drug Administration…

ActelionBiotechnologyRegulationRespiratory and PulmonaryselexipagUptraviUSA

63 to 87 of 2557 results

Back to top